Miss Jeanine Du Plessis

Jeanine Du Plessis is a South African clinical researcher whose work centers on infectious diseases, with a strong focus on COVID-19 epidemiology, vaccine efficacy, and pathological outcomes. Affiliated with leading academic and clinical institutions in South Africa, research contributions are closely linked to collaborative studies conducted at Chris Hani Baragwanath Academic Hospital and the University of the Witwatersrand.

Publications in high-impact journals, including the New England Journal of Medicine, Vaccine, and Clinical Infectious Diseases, highlight involvement in pivotal trials evaluating the ChAdOx1 nCoV-19 vaccine against emerging SARS-CoV-2 variants. This body of work has advanced understanding of variant-specific vaccine performance, durability of protection, and safety in diverse populations, particularly within the South African context.

Additional research explores histopathological findings in COVID-19-related deaths among adults and children, interactions with HIV and tuberculosis, and infection dynamics among healthcare workers. Earlier work on venous thromboembolism prophylaxis reflects a broader interest in evidence-based hospital medicine. Collectively, these studies demonstrate strengths in clinical investigation, multidisciplinary collaboration, and translational infectious disease research.